Welcome to the Journal of Behavior Therapy and Experimental Psychiatry, a distinguished publication in the field of psychological research, recognized for its commitment to advancing knowledge in behavior therapy and experimental psychiatry. Published by Pergamon-Elsevier Science Ltd in the United Kingdom, this journal plays a crucial role in disseminating innovative findings and theoretical advancements since its inception in 1970. With an impressive array of impact factors, this journal proudly holds a Q1 ranking in Arts and Humanities (miscellaneous) and Q2 rankings across Clinical Psychology, Experimental and Cognitive Psychology, and Psychiatry and Mental Health categories in 2023. The journal provides a platform for both established researchers and emerging scholars to share insights that enhance practice and inform policy in mental health. Although not an Open Access journal, it ensures broad accessibility to its content through institutional subscriptions and affiliations. By focusing on high-quality, rigorous research, the Journal of Behavior Therapy and Experimental Psychiatry continues to shape the understanding of behavioral interventions and their psychological implications, making it an indispensable resource for professionals and students alike.

Psychoterapia, published by the Polish Psychiatric Association, is an esteemed academic journal dedicated to the fields of clinical psychology and psychiatry. Established in 2001 and continuing its publication until 2023, this journal serves as a significant platform for the dissemination of research, clinical practices, and theoretical advancements in the realm of mental health. Although it currently holds a Q4 ranking in both the Clinical Psychology and Psychiatry and Mental Health categories, it is committed to improving the understanding and treatment of psychological disorders through rigorous peer-reviewed articles. With its ISSN 0239-4170 and E-ISSN 2391-5862, Psychoterapia provides vital insights that are of interest to researchers, clinicians, and students alike. While the journal does not offer open access options, it remains a recommended resource to further stimulate research and dialogue in the field of psychotherapy.

Journal of Psychopathology, published by PACINI EDITORE, is a pivotal academic resource in the realms of clinical psychology and psychiatry. With an ISSN of 1592-1107 for print and 2499-6904 for electronic formats, this journal has been a significant platform for scholarly discourse since its inception in 2001, continuing through to 2024. Situated in Pisa, Italy, it is recognized for its rigorous academic standards, as evidenced by its Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories as of 2023. The journal focuses on publishing high-quality research articles, reviews, and case studies that contribute to a comprehensive understanding of psychopathological issues. Although not open access, the journal promotes accessibility through various institutional subscriptions, ensuring wide dissemination of valuable insights. With significant Scopus rankings—177 out of 311 in Clinical Psychology and 360 out of 567 in Psychiatry and Mental Health—the journal is essential for researchers, practitioners, and students dedicated to advancing knowledge and practices in mental health.

The Iranian Journal of Psychiatry and Clinical Psychology, a distinguished publication by IRAN UNIV MEDICAL SCIENCES, serves as a vital platform for the dissemination of research and advancements in the fields of clinical psychology and psychiatry. With its ISSN 1735-4315 and E-ISSN 2228-7515, the journal reaches a diverse audience of researchers, practitioners, and students, specifically in Iran and the broader international community. This open access journal, based in Tehran, facilitates knowledge sharing through its commitment to exploring contemporary issues and emerging trends from 2018 to 2024. Recognized for its significant contributions, it has achieved a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories in 2023, alongside Scopus rankings that place it within the lower quartiles of its respective fields. The journal's aim is to foster a deeper understanding of mental health challenges, promote evidence-based practices, and enhance the quality of mental health care, making it an essential resource for advancing academic and clinical excellence.

Activitas Nervosa Superior Rediviva is a peer-reviewed journal dedicated to the fields of neuropsychology, physiological psychology, psychiatry, and mental health research. Published by the esteemed SLOVAK ACADEMY OF SCIENCES, INSTITUTE OF NORMAL AND PATHOLOGICAL PHYSIOLOGY, this journal embraces an open-access model, facilitating the dissemination of critical findings and discussions within these evolving fields. With a focus on innovative studies spanning from 2009 to 2024, it provides a vital platform for researchers and professionals seeking to understand the complexities of the nervous system and related disorders. Although currently classified in the fourth quartile across relevant categories including neuropsychology and psychiatric health, the journal’s commitment to publishing quality research contributes significantly to the ongoing discourse among academics and clinicians alike. Activitas Nervosa Superior Rediviva invites scholars to engage with its content and further strengthen the integration of research and practice in mental health and neurological sciences.

Trends in Psychiatry and Psychotherapy, published by ASSOC PSIQUIATRIA RIO GRANDE SUL, is a leading open-access journal dedicated to advancing the fields of psychiatry and mental health. Since its inception in 2011, this Brazilian journal has committed itself to disseminating high-quality research and innovative clinical practices, providing a platform for both established researchers and emerging voices in the field. With a notable impact factor and ranking within the Q2 quartile for both psychiatry and miscellaneous medicine categories in 2023, this journal is recognized for its significant contribution to the academic community. It serves as a vital resource for researchers, professionals, and students alike, facilitating knowledge exchange and fostering collaboration across disciplines. The open-access model ensures that cutting-edge findings are accessible to a global audience, enhancing the discourse surrounding mental health and psychiatric care. For more information and to explore current publications, please visit the journal's website.

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

The Journal of Affective Disorders is a premier publication in the field of Clinical Psychology and Psychiatry and Mental Health, published by Elsevier. With an impressive impact factor and a consistent ranking in the Q1 category—12th in Clinical Psychology and 40th in Psychiatry and Mental Health—the journal serves as a critical platform for advancing research on affective disorders since its inception in 1979. The journal’s scope encompasses a wide range of topics related to mood disorders, providing researchers, professionals, and students with the latest findings, theoretical developments, and clinical insights. Despite being a non-open-access journal, subscribers benefit from comprehensive access to high-quality, peer-reviewed articles that inform clinical practice and enrich academic discourse. With its commitment to fostering scientific progress, The Journal of Affective Disorders remains instrumental in shaping the future of mental health research and practice.

PSYCHIATRIE DE L ENFANT is a distinguished academic journal published by PRESSES UNIV FRANCE, focusing on the significant realm of child psychiatry and developmental psychology. With its ISSN 0079-726X and E-ISSN 2102-5320, this journal provides a platform for researchers, practitioners, and educators to explore various topics surrounding mental health in children. Although the coverage in Scopus has been discontinued since 2018, with ranks highlighting its placement in the Developmental and Educational Psychology and Psychiatry and Mental Health categories, the journal's contributions remain pivotal for professionals aiming to advance their understanding of child mental health. Though it does not currently offer open access, the journal invites rigorous studies, clinical insights, and theoretical discussions that are crucial for the evolution of child psychiatry. As such, PSYCHIATRIE DE L ENFANT plays an essential role in shaping future research and practices in the field.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.